🔎 Trials Near Me

Home › Pagkabigo ng Puso › Minnesota › Minneapolis

Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Minneapolis, MN

Isang pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Minneapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

ELEVATE-HFpEF Clinical Study

Nagre-recruit
  • M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06678841

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Nagre-recruitPhase 3
  • Minneapolis VA Health Care System, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Nagre-recruitPhase 3
  • Minneapolis VA Health Care System, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06424288

Alleviant ALLAY-HFrEF Study

Nagre-recruit
  • Minneapolis Heart Institute Foundation, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Nagre-recruitPhase 3
  • University of Minnesota, Minneapolis
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Nagre-recruitPhase 3
  • Research Site, Minneapolis
Edad 40 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Nagre-recruitPhase 3
  • Minneapolis, MN Investigative Site CON-10035, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Nagre-recruitPhase 3
  • Minneapolis, MN Investigative Site 10091, Minneapolis
  • Minneapolis, MN Investigative Site 10035, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Nagre-recruit
  • Abbott Northwestern Hospital, Minneapolis
  • University of Minnesota, Minneapolis
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06310031

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Nagre-recruitObservasyonal na pag-aaral
  • Minneapolis, Minneapolis
Lahat ng edad · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT00271180

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Nagre-recruitObservasyonal na pag-aaral
  • Minneapolis Heart Institute Foundation, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Nagre-recruitPhase 3
  • Tenax Investigational Site, Minneapolis
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07288398

Alleviant ALLAY-HF Study

Nagre-recruit
  • Minneapolis Heart Institute Foundation, Minneapolis
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT05685303

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Nagre-recruit
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Edad 60 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT05996328

Assessment of CCM in HF With Higher Ejection Fraction

Nagre-recruit
  • Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05064709

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Nagre-recruitPhase 3
  • Minneapolis, MN Investigative Site FIN-10035, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Nagre-recruit
  • University of Minnesota, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Nagre-recruit
  • Minneapolis Heart Institute, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06526195

CCM OPEN HF Registry

Nagre-recruitObservasyonal na pag-aaral
  • Minneapolis Heart Institute Research Foundation, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT07112924

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Nagre-recruitObservasyonal na pag-aaral
  • Minneapolis Heart Institute Foundation, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 23, 2025 · NCT07131631

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Nagre-recruitObservasyonal na pag-aaral
  • Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update May 22, 2024 · NCT06425848

Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod

Iba pang pag-aaral sa Minneapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.